Global Bioresorbable Scaffolds Market, By Material (Absorbable Magnesium Stent (AMS), Polymeric Scaffold, Poly Carbonate Scaffold, Others), Types (Drug Eluting Coronary Scaffolds, Everolimus-Eluting Device, Novolimus-Eluting Device, Sirolimus-Eluting Device, Paclitaxel-Eluting Device), Applications (Peripheral Vascular Intervention, Regulation of Blood Flow and Others), End Users (Hospitals, Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Bioresorbable Scaffolds Market
The bioresorbable scaffolds market is expected to witness market growth at a rate of 14.80% in the forecast period of 2021 to 2028 and is expected to reach USD 2,716.31 million by 2028. Data Bridge Market Research report on bioresorbable scaffolds market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increase in the prevalence of lifestyle related disorders globally is escalating the growth of bioresorbable scaffolds market.
Bioresorbable scaffolds (BRSs) are specifically designed for the purpose of decreasing events related to permanent metallic stents as they provide subsequent complete resorption and temporal mechanical support. The BRS hypothesis is said to be built on the assumption that the absence of metallic caging would facilitate full restoration of vasomotion and induce luminal enlargement.
The rise in the prevalence of cardiovascular diseases (CVD) among population across the globe acts as one of the major factors driving the growth of bioresorbable scaffolds market. The increase in adoption for cardiovascular surgeries owning to the various benefits offered such as full absorption by the body and increase in incidences of lifestyle related diseases such as diabetes and obesity among others accelerate the bioresorbable scaffolds market growth. The rise in adoption of unhealthy lifestyle patterns such as consumption of alcohol, poor diet and lack of exercise and innovations made by key players in order to naturally restore movement of artery further influences the bioresorbable scaffolds market. Additionally, changing lifestyle, growth in population, rise in the number of cardiovascular surgeries and surge in healthcare expenditure positively affect the bioresorbable scaffolds market. Furthermore, research and development activities to prevent vessel recoil that enables secretion of anti-proliferative drug extend profitable opportunities to the bioresorbable scaffolds market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with bioresorbable scaffolds is expected to obstruct the bioresorbable scaffolds market growth. The rise in preference for vascular graft devices for angioplasty and coronary artery diseases is projected to challenge the bioresorbable scaffolds market in the forecast period of 2021-2028.
This bioresorbable scaffolds market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on bioresorbable scaffolds market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Bioresorbable Scaffolds Market Scope and Market Size
The bioresorbable scaffolds market is segmented on the basis of material, types, applications and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of material, the bioresorbable scaffolds market is segmented into absorbable magnesium stent (AMS), polymeric scaffold, poly carbonate scaffold and others.
- On the basis of types, the bioresorbable scaffolds market is segmented into drug eluting coronary scaffolds, everolimus-eluting device, novolimus-eluting device, sirolimus-eluting device and paclitaxel-eluting device.
- On the basis of applications, the bioresorbable scaffolds market is segmented into peripheral vascular intervention, regulation of blood flow and others.
- On the basis of end users, the bioresorbable scaffolds market is segmented into hospitals, clinics and others.
Global Bioresorbable Scaffolds Market Country Level Analysis
The bioresorbable scaffolds market is analyzed and market size insights and trends are provided by country, material, types, applications and end users as referenced above.
The countries covered in the global bioresorbable scaffolds market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the bioresorbable scaffolds market due to the large number of people suffering from cardiovascular diseases, increase in obese and diabetic population, rise in stress and desk-bound lifestyle, large geriatric population and presence of number of leading companies. Asia-Pacific is expected to witness the fastest growth during the forecast period of 2021 to 2028 because of the rapid development in technology and a huge number of patients suffering from different vascular diseases.
The country section of the bioresorbable scaffolds market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The bioresorbable scaffolds market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bioresorbable scaffolds market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on bioresorbable scaffolds market. The data is available for historic period 2011-2019.
Competitive Landscape and Bioresorbable Scaffolds Market Share Analysis
The bioresorbable scaffolds market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to bioresorbable scaffolds market.
The major players covered in the bioresorbable scaffolds market report are Abbott, Medtronic, Boston Scientific Corporation, BIOTRONIK, Elixir Medical, REVA Medical, Inc., Amaranth Medical, MEDICAL PLANNING Co., Ltd., SEC.report, B. Braun Melsungen AG, Cardinal Health, Lombard Medical Limited, Translumina, MicroPort Scientific Corporation, Terumo Corporation, Cook, W. L. Gore & Associates, Inc., BD, STENTYS SA, Devex among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-